ANXA2 and colorectal carcinoma: XAB2 binds to the ANXA2 promoter, activating its transcriptional activity, thereby promoting CRC cell proliferation and DNA damage response, repairing oxaliplatin-induced DNA damage, and enhancing oxaliplatin resistance.